GlassScriptPhysician profile
John S Kirchner
NPI 1952379521
$84,289.04
in general payments reported to CMS, 2019-2025
34 companies · $1,215 in 2025
The $1,215 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,202 · 2020: $12K · 2021: $60K · 2022: $813 · 2023: $1,674 · 2024: $751 · 2025: $1,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2,650 · Food and Beverage: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,649.91 |
| Food and Beverage | $989.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $60,310.98 | 2019-2021 | |
| Trimed, INC. | $5,649.89 | 2019 | |
| Osteomed LLC | $4,131.00 | 2020 | |
| Ascension Orthopedics, INC. | $3,687.50 | 2020 | |
| Integra Lifesciences Corporation | $2,976.59 | 2019-2020 | |
| Acumed LLC | $2,649.91 | 2023-2025 | Osteomed |
| Crossroads Extremity Systems, LLC | $2,107.83 | 2019-2020 | |
| Treace Medical Concepts, INC. | $687.40 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $497.26 | 2020 | |
| Stryker Corporation | $332.07 | 2023-2025 | Gravity Synchfix, Augment Injectable, Citrefix |
| Horizon Therapeutics Plc | $221.60 | 2022-2023 | Krystexxa |
| Amgen INC. | $142.93 | 2020-2025 | Krystexxa |
| Depuy Synthes Sales INC. | $124.46 | 2021-2023 | Orthovisc |
| Kerecis Limited | $87.46 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Pacira Therapeutics, INC. | $82.56 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $71.12 | 2019 | |
| Bioventus LLC | $67.85 | 2019-2024 | Stimrouter Implantable Kit, Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $53.44 | 2024 | Stratafix, Vistaseal |
| Ermi LLC | $44.97 | 2020-2021 | |
| Boston Scientific Corporation | $43.09 | 2023-2025 | Spectra Wavewriter |
| Zimmer Biomet Holdings, INC. | $40.19 | 2021 | |
| Solventum Corporation | $40.16 | 2024-2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Smith+Nephew, INC. | $32.73 | 2019-2023 | Pico 14, Renasys Go V2 Home |
| Endo Pharmaceuticals INC. | $29.59 | 2019 | |
| Davol INC. | $24.32 | 2022 | |
| Paragon 28, INC. | $23.97 | 2019 | |
| Wright Medical Technology, INC. | $22.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.08 | 2025 | |
| Abbvie INC. | $17.73 | 2024 | |
| Access Pro Medical, LLC | $16.76 | 2025 | Matriderm |
| Arteriocyte Medical Systems, INC. | $16.43 | 2023 | Magellan |
| Pfizer INC. | $14.12 | 2020 | |
| Avanos Medical | $12.30 | 2022 | |
| Si-Bone, INC. | $9.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kirchner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.